Figure 2
From: Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
Hierarchical clustering of mRNA expression in each tumor suggests MT19c treatment is the defining feature of the panel of xenograft tumors. A. All samples were clustered by HCE Hierarchical Clustering Explorer revealing four major groups. Outliers are in black. B. Tumors collected after 16 days were removed from the clustering revealing two distinct classes defined by MT19c treatment.